SRx Global Inc

Análisis de la acción SRx Global Inc (SRXH)

$0.811

+0.011 (+1.39%)Al cierre

Loading chart…
Máximo
0.838
Apertura
0.808
Precio medio ponderado por volumen
0.81
Volumen
280.74K
Capitalización
—
Mínimo
0.790
Importe
228.26K
EV/EBITDA, TTM
0.00

SRx Global Inc. is an artificial intelligence (AI)-driven platform focused on investments in high-conviction operating companies, strategic assets, and technology-enabled opportunities. The Company leverages proprietary technology, data analytics, and disciplined capital allocation to identify and manage investments across multiple sectors. Its portfolio includes EMJX and Halo pets. EMJX is a digital-asset treasury platform designed as a treasury operating system, applying models, artificial intelligence, and systematic risk controls to multi-asset digital treasury management. Halo pets is engaged in selling premium pet products for dogs and cats. Halo pets offer Dry Food, Freeze-Dried Raw, Wet Food, Toppers, Dental, Treats & Chews, and others. Its dry food includes Freeze-Dried Raw Beef Meal Bites 14 oz, Freeze-Dried Raw Turkey Meal Bites 14 oz, Holistic Vegan Plant-Based with Superfoods Recipe Adult Dry Dog Food, and others.

Análisis de IA of SRx Global Inc (SRXH)

Vender

Currently, SRx Health Solutions Inc (SRXH) is not a good buy. The stock has experienced a drastic year-to-date decline of 94.32% and a 5-day change of -19.69%, indicating severe downward momentum. The RSI is at a low 10.521, suggesting the stock is oversold but also reflecting weak demand. Additionally, the forward P/E ratio is 0, indicating a lack of expected earnings growth. The main risk is the significant debt burden reflected in the current ratio of 27.55, which, while indicating liquidity, shows a volatile financial position. Given these factors, it is advisable to avoid purchasing SRXH at this time.

Métricas de valoración

El PER previsto actual de SRx Global Inc (SRXH) es 0.00, frente a su media de 5 años de 0.00.

PER previsto

Muy infravalorado
Media 5A P/E
0.00
P/E actual
0.00
Sobrevalorada
0.00
Infravalorada
0.00

EV/EBITDA previsto

Muy infravalorado
Media 5A EV/EBITDA
0.00
EV/EBITDA actual
0.00
Sobrevalorada
0.00
Infravalorada
0.00

Precio/ventas previsto

Muy infravalorado
Media 5A P/S
0.00
P/S actual
0.00
Sobrevalorada
0.00
Infravalorada
0.00

Escenarios de precio de Alphio AI para SRXH

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%SRXH

$0.65

Precio del escenario

B

Base

Base · 50%SRXH

$0.61

Precio del escenario

B

Bajista

Bajista · 25%SRXH

$0.58

Precio del escenario

Cronología de eventos

2026-08-04 (ET)

05:30:00

SRX Global Acquires Stake in Vistagen

2026-07-30 (ET)

14:30:00

SRX Global Acquires Shares in Jersey Mike's IPO

2026-07-09 (ET)

12:00:00

SRx Global Inc Trading Halted, News Pending

12:00:00

SRX Global Authorizes Repurchase of Up to 10M Shares

2026-07-08 (ET)

14:00:00

SRx Global Inc Trading Halted, News Pending

Noticias

Preguntas frecuentes sobre SRXH, respondidas por Alphio AI

SRx Global Inc. is an artificial intelligence (AI)-driven platform focused on investments in high-conviction operating companies, strategic assets, and technology-enabled opportunities. The Company leverages proprietary technology, data analytics, and disciplined capital allocation to identify and manage investments across multiple sectors. Its portfolio includes EMJX and Halo pets. EMJX is a digital-asset treasury platform designed as a treasury operating system, applying models, artificial intelligence, and systematic risk controls to multi-asset digital treasury management. Halo pets is engaged in selling premium pet products for dogs and cats. Halo pets offer Dry Food, Freeze-Dried Raw, Wet Food, Toppers, Dental, Treats & Chews, and others. Its dry food includes Freeze-Dried Raw Beef Meal Bites 14 oz, Freeze-Dried Raw Turkey Meal Bites 14 oz, Holistic Vegan Plant-Based with Superfoods Recipe Adult Dry Dog Food, and others. It operates in the Technology sector.

Currently, SRx Health Solutions Inc (SRXH) is not a good buy. The stock has experienced a drastic year-to-date decline of 94.32% and a 5-day change of -19.69%, indicating severe downward momentum. The RSI is at a low 10.521, suggesting the stock is oversold but also reflecting weak demand. Additionally, the forward P/E ratio is 0, indicating a lack of expected earnings growth. The main risk is the significant debt burden reflected in the current ratio of 27.55, which, while indicating liquidity, shows a volatile financial position. Given these factors, it is advisable to avoid purchasing SRXH at this time.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Artículos relacionados

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar